Skip to content

Medical emergency? What to do

Stroke-prevention drug underutilized in minorities

3-RXPublished March 10, 20063 min read

Key points

  • Despite its proven efficacy in reducing the risk of stroke in patients with abnormal heart rhythm, the blood thinner warfarin is less commonly given to racial minorities, even though their risk of stroke is higher than that of whites, a new study shows.
  • In a second journal paper, researchers found that physicians often don't prescribe warfarin for patients over the age of 80 who have atrial fibrillation, even though their risk of stroke is high.
  • Warfarin was prescribed for 49.1 percent of patients at discharge.
  • Warfarin use was associated with a 35-percent reduction in strokes, which compares poorly to the 65-percent reduction observed in clinical trials, the authors note.

Despite its proven efficacy in reducing the risk of stroke in patients with abnormal heart rhythm, the blood thinner warfarin is less commonly given to racial minorities, even though their risk of stroke is higher than that of whites, a new study shows.

Furthermore, only about half of older patients in the United States hospitalized with abnormal heart rhythm, also referred to as atrial fibrillation, are prescribed warfarin when they are discharged, according to a report in the journal Stroke. Atrial fibrillation increases the risk of blood clot. By "thinning" the blood, warfarin can prevent the formation of these clots, which are the most common cause of strokes.

In a second journal paper, researchers found that physicians often don't prescribe warfarin for patients over the age of 80 who have atrial fibrillation, even though their risk of stroke is high. Failure to prescribe the drug is frequently attributed to other existing conditions that would put the patient at risk for complications.

Dr. Brian F. Gage, from Washington University School of Medicine in St. Louis, and his associates created a National Registry of Atrial Fibrillation II data set. Their analysis included Medicare beneficiaries (i.e., at least 65 years old) hospitalized with atrial fibrillation between April 1998 and March 1999. The study consisted of 16,007 non-Hispanic whites, 797 blacks, and 468 Hispanic subjects.

Warfarin was prescribed for 49.1 percent of patients at discharge. Even among "ideal candidates" -- those with a high risk of stroke and few reasons for not receiving the drug -- warfarin was prescribed for only 64.6 percent.

Overall, warfarin was prescribed for 49.7 percent of whites, 43.2 percent of blacks, and 40.2 percent of Hispanics. Compared with whites, blacks and Hispanics who were prescribed warfarin were more likely not to be monitored during the first 90 days (9.7 percent, 21.3 percent and 16.7 percent, respectively) and at regular interval after 90 days.

Warfarin use was associated with a 35-percent reduction in strokes, which compares poorly to the 65-percent reduction observed in clinical trials, the authors note. The drug was even less effective in preventing stroke among minority patients.

Gage's team suggests that poor follow-up probably contributes to warfarin's reduced efficacy among blacks and Hispanics, as well as their increased risk of strokes unrelated to blood clots (for which warfarin provides less effective prevention) and their higher risk of diabetes and high blood pressure.

To determine the reasons why physicians don't prescribe warfarin for patients with atrial fibrillation, Dr. Elaine M. Hylek at Boston University School of Medicine and her associates followed 405 patients age 65 or older who were admitted to a hospital for atrial fibrillation between 2001 and 2003.

They found that 51 percent of the patients were started on warfarin: 75 percent of those 65 to 69 years old, 59 percent of those 70 to 79, 45 percent of those 80 to 89, and 24 percent of those age 90 or older.

The most common reasons that physicians cited for not prescribing warfarin were hemorrhage (33 percent), falls (32 percent) and patient refusal or history of nonadherence (14 percent). Other reasons included mental impairment, alcohol abuse and advanced illness.

Approximately 75 percent of those not prescribed warfarin were put on aspirin or aspirin plus clopidogrel, which are less effective than warfarin at preventing stroke.

Strategies are needed to increase treatment eligibility of elderly patients, particularly reducing the risk of hemorrhage and falls, Hylek's team maintains. They also call for research to find alternative stroke prevention strategies that don't increase hemorrhagic risk.

SOURCE: Stroke, April 2006.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underStroke

Keep reading

Stroke

Useful stroke trials left unpublished

An investigation into unpublished stroke research data has revealed that 19.6% of completed clinical trials, which could potentially influence patient care, are not published in full. Researchers writing in BioMed…

3 min read

Trauma

Different strokes help tissue heal

Using simple handheld tools, physical therapist Laurie Eickhoff carefully rubs patient Lisa Maharry's leg to treat her Achilles injury with a new therapy intended to stimulate the body's normal healing process.…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.